Lawsuit: Drugmaker improperly used charity to pay kickbacks

PHILADELPHIA — Federal prosecutors say a pharmaceutical firm improperly used a charity to pay kickbacks that subsidized Medicare patients' copayment obligations, allowing the firm to keep raising prices for the drug.

The suit filed Wednesday claims the scheme was designed to enable Mallinckrodt to raise the price of Acthar from $50 to $32,000. The drug is used to treat acute exacerbations in multiple sclerosis, lupus and rheumatoid arthritis.

Mallinckrodt could face fines of nearly $240 million. Prosecutors say the scheme operated from 2010-2014, causing the submission of millions of dollars in false Medicare claims for the drug. Drug companies are not allowed to cover patients' copayments.

Mallinckrodt said it intends to vigorously defend itself against the allegations.

Must Read

Asian stocks drift pending fresh news; oil takes a breather

Aug 16, 2016

Asian stock markets drifted sideways on Tuesday as the price of oil took a breather from a three-day rally

Asian stocks mostly higher after Wall Street decline

Aug 17, 2016

Asian stock markets were mostly higher Wednesday after Wall Street declined

Bolt advances, Russian qualifies and an engagement at track

Aug 17, 2016

The midpoint of the nine-day track and field program at Olympic Stadium was a day for diamond rings and making friends, a rare Russian hello and a surprising Brazilian farewell

Search

Obserworld delivers the most accurate and up-to-date world news for the global audience with a thorough research and in-depth interviews. Discover the world through Obserworld.

Contact us: sales[at]obserworld.com